Mark Kirschbaum

Mark Kirschbaum currently serves as the Chief Medical Officer at CBCC Global Research since November 2024 and is the Founder and President of Midtown Biopharma Consulting, LLC since August 2024. Previously, Mark held the position of Chief Medical Officer at Cyclacel Pharmaceuticals, Inc. from October 2020 to February 2024, and served as VP at ArQule from October 2019 to October 2020. Mark also worked as Senior Medical Director at Daiichi Sankyo, Inc. from March 2019 to October 2020. Mark's academic background includes education from the University of Washington and Yeshiva University.